IP Library › Granted Patent US 6,974,578
Granted Patent B1
US 6,974,578 · App. 08/627,118 · Granted Dec 13, 2005

Method for treating secretions and glands using botulinum toxin

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,974,578
App. No.
08/627,118
Granted
Dec 13, 2005
Kind
B1
Abstract

Method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of, Botulinum toxin types A, B, C, D, E, F and G.

Claims (12)

1. A method of treating a secretion of a patient, the method comprising the step of administering to the patient an effective amount of Botulinum toxin in order to reduce the secretion, wherein the secretion is sweat.

2. The method of claim 1 , wherein the secretion is a cholinergic influenced secretion.

3. The method of claim 1 , wherein the botulinum toxin is botulinum toxin type A.

4. A method for treating a cholinergic influenced sweat secretion of a human patient, the method comprising the step of administering to a human patient a therapeutically effective amount of botulinum toxin type A in order to reduce the sweat secretion.

5. A method for treating a gland, the method comprising the step of administering to a gland a botulinum toxin thereby reducing a secretory activity of the gland, wherein the gland is a sweat gland.

6. The method of claim 5 , wherein the gland is an excessively secreting sweat gland.

7. The method of claim 5 , wherein the sweat gland is influenced by the cholinergic nervous system.

8. The method of claim 5 , wherein the botulinum toxin is botulinum toxin type A.

9. The method of claim 5 , wherein the botulinum toxin is administered by injection into the sweat gland or into the local area of the sweat gland.

10. A method for treating an excessively secreting sweat gland, the method comprising the step of injecting an excessively secreting, cholinergic nervous system influenced sweat gland or local sweat gland area of a human patient with a therapeutically effective amount of botulinum toxin type A in order to reduce the excessive sweat gland secretion.

11. The method of claim 1 , wherein the botulinum toxin is selected from the group consisting of botulinum toxin types A, B, C, D, E, F and G.

12. The method of claim 5 , wherein the botulinum toxin is selected from the group consisting of botulinum toxin types A, B, C, D, E, F and G.